In vivo and in vitro metabolism of aspirin eugenol ester in dog by liquid chromatography tandem mass spectrometry.

Abstract

Aspirin eugenol ester (AEE) is a promising drug candidate for treatment of inflammation, pain and fever and prevention of cardiovascular diseases with fewer side effects than its precursor, aspirin. Investigation into its metabolic process in target animal species will help to illustrate its mechanism of action and to establish its residual mark compound to formulate its dosage. Six beagle dogs were orally given a dose of 20 mg kg(-1) of AEE and one dog was used to prepare blank liver microsomes. Their liver microsomes were prepared for in vitro study and their plasma and urine were collected for in vivo metabolic analysis using liquid chromatography tandem mass spectrometry. In this study we identified 10 metabolites, M1, M2, M3, M4, M5 in phase I and M6, M7, M8, M9, M10 in phase II. Based on the metabolites of AEE, the pathways of AEE metabolism in dog were demonstrated.

• Authors: Youming Shen, Xiwang Liu, Yajun Yang, Jianyong Li, Ning Ma, Bing Li
• Journal: Biomedical chromatography : BMC (Biomed Chromatogr) Vol. 29 Issue 1 Pg. 129-37 (Jan 2015) ISSN: 1099-0801 [Electronic] England
• PMID: 24935248 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2014 John Wiley & Sons, Ltd.

Chemical References

• aspirin eugenol ester
• Eugenol
• Aspirin

Topics

• Animals
• Aspirin (analogs & derivatives, blood, chemistry, metabolism, urine)
• Chromatography, Liquid (methods)
• Dogs
• Eugenol (analogs & derivatives, blood, chemistry, metabolism, urine)
• Female
• Male
• Metabolic Networks and Pathways
• Microsomes, Liver (chemistry, metabolism)
• Tandem Mass Spectrometry (methods)